跳至主要内容
临床试验/NCT03368794
NCT03368794撤回不适用

Naloxone to TReatment Entry in the Emergency Setting

Anders C Håkansson1 个研究点 分布在 1 个国家开始时间: 2017年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Treatment entry

研究概览

简要总结

The study tests a structured referral process for opioid overdose survivors, from pre-hospital emergency care to long-term treatment of the individual's substance use-related disorder.

详细描述

Randomized controlled trial. Subjects are included if they are being treated by an ambulance in the Malmö uptake are for an opioid overdose requiring naloxone antidote administration, and if they sign informed written consent to the study. Subjects are randomized by ambulance staff to either an active intervention, or a control condition:

Intervention: A telephone alert signal is sent from ambulance staff after successful naloxone reversal of an opioid overdose, leading to an active outreach effort from the staff of the addiction research facility, where staff locate the individual and offer her/him formal inclusion in the study.

Control: No telephone alert signal is sent, and the active outreach procedure is not carried out. Ambulance staff hand over written information to the individual about how she/he can apply actively for treatment.

Primary outcome is entry into formal assessment and treatment of the substance use disorder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • survivor of opioid overdose requiring antidote naloxone administration by ambulance staff, and provision of written informed consent

排除标准

  • patients unable to understand study information and to provide informed consent

结局指标

主要结局

Treatment entry

时间窗: Two weeks

Entry into formal assessment for evidence-based treatment of opioid use disorder

次要结局

  • Treatment outcome (quality of life)(3, 6, 12, 24 and 36 months)
  • Treatment outcome (self-report)(3, 6, 12, 24 and 36 months)
  • Treatment outcome (urinalysis)(3, 6, 12, 24 and 36 months)
  • Treatment retention(3, 6, 12, 24 and 36 months)
  • Treatment outcome (hair analysis)(3 months)

研究者

发起方
Anders C Håkansson
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Anders C Håkansson

MD, PhD

Region Skane

研究点 (1)

Loading locations...

相似试验